HIV News and Research

RSS

AI may help identify potential gonorrhea vaccine proteins

Gonorrhea, a sexually transmitted bacterial infection that affects more than 80 million people worldwide every year, has become resistant to almost all known antibiotics.

31 Oct 2023

Brain autopsy study of intimate partner violence victims shows extensive brain damage

The largest brain autopsy study of women who had experienced intimate partner violence reveals substantial vascular and white matter damage in the brain, but no evidence of chronic traumatic encephalopathy (CTE), the neurodegenerative disease recognized among male contact sports athletes who sustain repeated head trauma.

30 Oct 2023

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

Researchers found that SARS-CoV-2 antigens can persist in the body for up to 14 months after initial infection, challenging the idea that COVID-19 is a transient illness. This finding has implications for understanding long-term effects of the virus and could influence future treatments and vaccines.

30 Oct 2023

Current jargon on antibiotic resistance fails to stick or scare, study finds

Researchers find that current terminology related to antimicrobial resistance (AMR) fails to effectively communicate the risks to the public. The study reveals that terms like "AMR" and "antimicrobial resistance" are poorly remembered and do not evoke sufficient risk perception, highlighting the need for improved public health messaging.

29 Oct 2023

Groundbreaking research advances understanding of how pathogens impact cancer

Viral infections are known to be a central cause of more than 10% of cancers worldwide. University of California researchers may have uncovered one of the key reasons why.

26 Oct 2023

Oxford Vaccine Group launches a pioneering study into human immunity

This study will test the responses of cells in lymph nodes before and after immunization with flu and COVID-19 vaccines and compare reactions in older and younger adults.

25 Oct 2023

Epidemic: What good is a vaccine when there is no rice?

The 1970s was the deadliest decade in the "entire history of Bangladesh," said environmental historian Iftekhar Iqbal

24 Oct 2023

University of Montana awarded $12.3 million contract to develop novel vaccine adjuvant for TB vaccine

The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for use in a tuberculosis vaccine. Adjuvants are substances that boost the effectiveness of vaccines.

24 Oct 2023

Health care ‘game-changer’? Feds boost care for homeless Americans

The Biden administration is making it easier for doctors and nurses to treat homeless people wherever they find them, from creekside encampments to freeway underpasses, marking a fundamental shift in how — and where — health care is delivered.

19 Oct 2023

Two NIAID grants will support research on impacts of climate change on HIV-related health outcomes

Two grants from the National Institute of Allergies and Infectious Diseases (NIAID), a four-year $3.2 million award and a 12-month $550,000 administrative supplement, will support innovative research to advance the understanding of how climate change and extreme weather influence HIV-related health outcomes around the world.

18 Oct 2023

Pregnant and addicted: Homeless women see hope in street medicine

Five days after giving birth, Melissa Crespo was already back on the streets, recovering in a damp, litter-strewn water tunnel, when she got the call from the hospital.

18 Oct 2023

Menstrual cups can be a great option for menstrual hygiene management, new trial shows

Menstrual cups may result in fewer infections and improve vaginal health, a new trial led by Liverpool School of Tropical Medicine shows.

17 Oct 2023

Promising breakthroughs ignite hope for a novel and effective Tuberculosis vaccine

The success and challenges of developing different tuberculosis (TB) vaccine types.

17 Oct 2023

Paxlovid treatment provides protection against COVID-19 for both mother and child

A new mouse model of infection with the COVID-19-causing SARS-CoV-2 virus during pregnancy tracks closely the disease course doctors have observed in SARS-CoV-2-infected pregnant patients, and suggests that treatment with the antiviral Paxlovid provides protection for both mother and child.

16 Oct 2023

Are people with HIV at a higher risk of severe COVID-19 outcomes?

The research review indicates that people with HIV, especially those with low CD4 cell counts, face greater risks of severe COVID-19 outcomes and have suboptimal immune responses to SARS-CoV-2. Antiretroviral therapy aids in clearing infections, and a third vaccine dose reduces the risk of breakthrough infections among this population.

15 Oct 2023

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

The research paper explores the multifaceted role of the IL-17 family in immune response, covering everything from infection control to pathological conditions like autoimmune diseases and cancer. Future therapies may exploit IL-17's unique signaling pathways to offer more targeted and cost-effective treatments.

12 Oct 2023

EVScape: New tool to forecast which SARS-CoV-2 variants could dodge our immunity

Researchers have developed EVScape, a predictive tool that identifies which SARS-CoV-2 strains are most likely to evade host immunity. Utilizing a deep generative model and structural information, the tool offers early warning about viral variants, aiding in the timely development of effective vaccines and treatments.

12 Oct 2023

Generic PrEP use could reduce new HIV acquisitions, save lives among young men who have sex with men

Anne Neilan, MD, a physician-scientist in the division of Infectious Diseases at Massachusetts General Hospital is the senior author of a recently published paper in Clinical Infectious Diseases, Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-Saving at Generic Drug Price.

12 Oct 2023

KFF Health News' 'What the Health?': Health funding in question in a speaker-less Congress

As House Republicans struggle — again — to decide who will lead them, the clock is ticking on a short-term spending bill that keeps the federal government running only until mid-November.

12 Oct 2023

PrEP, a key HIV prevention tool, isn’t reaching Black women

Alexis Perkins thought her OB-GYN's office in Atlanta would be just the place to get a prescription for the type of drug that reduces a person's risk of contracting HIV.

12 Oct 2023

HIV News and Research

AI may help identify potential gonorrhea vaccine proteins

Brain autopsy study of intimate partner violence victims shows extensive brain damage

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

Current jargon on antibiotic resistance fails to stick or scare, study finds

Groundbreaking research advances understanding of how pathogens impact cancer

Oxford Vaccine Group launches a pioneering study into human immunity

Epidemic: What good is a vaccine when there is no rice?

University of Montana awarded $12.3 million contract to develop novel vaccine adjuvant for TB vaccine

Health care ‘game-changer’? Feds boost care for homeless Americans

Two NIAID grants will support research on impacts of climate change on HIV-related health outcomes

Pregnant and addicted: Homeless women see hope in street medicine

Menstrual cups can be a great option for menstrual hygiene management, new trial shows

Promising breakthroughs ignite hope for a novel and effective Tuberculosis vaccine

Paxlovid treatment provides protection against COVID-19 for both mother and child

Are people with HIV at a higher risk of severe COVID-19 outcomes?

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

EVScape: New tool to forecast which SARS-CoV-2 variants could dodge our immunity

Generic PrEP use could reduce new HIV acquisitions, save lives among young men who have sex with men

KFF Health News' 'What the Health?': Health funding in question in a speaker-less Congress

PrEP, a key HIV prevention tool, isn’t reaching Black women

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News